ODDB.org: Open Drug Database

Mepha Pharma AG - Sitagliptin-Metformin-Mepha 50/850 mg, Filmtabletten

Swissmedic Registration	68378	Sequence	02
Product name	Sitagliptin-Metformin-Mepha 50/850 mg	Description	Filmtabletten
ATC-Classification	A10BD07	ATC-Description	Metformin and Sitagliptin
Introduction of Sequence	05.04.2022

Composition

metformini hydrochloridum 850 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum K 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: lactosum monohydricum 13.7 mg, hypromellosum, E 171, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Metformin Hydrochloride	850 mg
Sitagliptine	50 mg

BAG: Active Agent	Dose
Metformin Hydrochloride	850 mg
Sitagliptine	50 mg

Inactive agents	Dose	additional_information
(Rubrum)
Cellulosum Microcristallinum
E 171		color.
E 172		color.
Hypromellosum
Lactose Monohydrate	13.7 mg	Überzug
Natrii Laurilsulfas
Natrii Stearylis Fumaras
Povidonum K	29-32
Pro Compresso Obducto
Triacetinum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	56	9.50	19.10	B	SL	Yes
004	196	33.27	54.65	B	SL	Yes
007	100	16.97	35.90	B	SL	Yes
009	196	PR	PR	B		No

2024	©ywesee GmbH